Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: A general practice study

Headache

Volumn 45, Issue 4, 2005, Pages 274-282

  Dowson, Andrew J ^a   Kilminster, Shaun G ^b   Salt, Rebecca ^c   Clark, Matthew ^c   Bundy, Michael J ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c Cranleigh Health Centre   (United Kingdom)

Author keywords

General practice; Headache; Impact; Menstruation; Migraine

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISABILITY; FEMALE; GENERAL PRACTICE; HEADACHE; HUMAN; MENSTRUAL CYCLE; MIGRAINE; PAIN; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RANK SUM TEST; TIME; UNITED KINGDOM;

ADOLESCENT; ADULT; DEPRESSION; DISABLED PERSONS; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HEADACHE DISORDERS; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN; QUESTIONNAIRES;

EID: 17244370245     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05064.x     Document Type: Article

References (21)

1. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA. 1992;267:64-69.
2. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000;13:277-283.
3. Smith AL, Weissmann MM. Depression. In: Paykel ES, ed. Handbook of Affective Disorders. London: Churchill Livingstone; 1992:111-129.
4. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-418.
5. Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics. 1998;13:667-676.
6. MacGregor EA. Gynaecological aspects of migraine. Rev Contemp Pharmacother. 2000;11:75-90.
7. MacGregor EA, Igarashi H, Wilkinson M. Headaches and hormones: subjective versus objective assessment. Headache Q. 1997;8:126-136.
8. Solbach P, Sargent J, Coyne L. Menstrual migraine headache: results of a controlled, experimental, outcome study of non-drug treatments. Headache. 1984;24:75-78.
9. Stewart WF, Lipton RB, Chee E, et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000;55:1517-1523.
10. Kennan PA, Lindamer LA. Non-migraine headache across the menstrual cycle in women with and without premenstrual syndrome. Cephalalgia. 1992;12:356-359.
11. Gross MLP, Barrie M, Bates D, et al. The efficacy of sumatriptan in menstrual migraine. Eur J Neurol. 1995;2:144-145.
12. Silberstein SD, Massiou H, Le Jeunne C, et al. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol. 2000;96:237-242.
13. Gauthier JG, Fournier AL, Roberge C. The differential effects of biofeedback in the treatment of menstrual and nonmenstrual migraine. Headache. 1991;31:82-90.
14. Lipton RB, Goadsby PJ, Sawyer JPC, et al. Migraine: diagnosis and assessment of disability. Rev Contemp Pharmacother. 2000;11:63-73.
15. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-92.
16. Lipton RB, Cady RK, Stewart WF, et al. Diagnostic lessons from the spectrum study. Neurology. 2002;58:S27-S31.
17. Dowson A, Dahlof C, Tepper S, et al. The spectrum of headaches experienced by migraineurs in a primary care setting. Cephalalgia. 2002;22:591.
18. Lipton RB, Stewart WF, Cady RK, et al. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000;40:783-791.
19. Henry P, Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology. 2002;59:232-237.
20. Kosinski M, Bjorner JB, Dahlof C, et al. Development of HIT-6, a paper-based short form for measuring headache impact [abstract]. Cephalalgia. 2001;21:334.
21. Kilminster SG. Manual for the Short Pain Inventory. West Sussex (UK): Lawrencian Clinical Publications and Selsey Press Ltd; 1998.